AMP Health logo

AMP Health Review

6.6
★★★☆☆3.3/5
Site is down for maintenance and not taking orders

AMP Health is no longer available as we reviewed it, so this page is kept for reference.

AMP Health: Site is down for maintenance and not taking orders. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.

See our top-rated GLP-1 providers →
Compare top-rated alternatives ↓

AMP Health was a telehealth service that sold compounded semaglutide (injectable and oral) and tirzepatide with a monthly subscription fee on top, and it appears to be a rebrand of the earlier SlimMD service. Its website has shown only a maintenance page since at least June 2026, with no store, prices or sign-up, so it is not taking orders.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Website in maintenanceNot taking orders

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to AMP Health

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
AMP Health logo
3.3 / 5
Our editorial rating

AMP Health at a glance

Type
GLP-1 telehealth provider
FDA status
1 FDA warning letter on record; see below

How we scored AMP Health

Each dimension is scored algorithmically from AMP Health'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.8/10

AMP Health no longer sells GLP-1 treatment, so no current price applies.

Effectiveness25%

6.2/10

AMP Health no longer offers GLP-1 treatment, so there is no current medication lineup to assess.

User Experience15%

7.6/10

Online intake and platform experience; 2 platform features disclosed.

Trust & Safety15%

5.7/10

Core details confirmed by our editors; an FDA warning letter is on file (see the regulatory notice on this page).

Accessibility10%

6.8/10

AMP Health no longer offers GLP-1 treatment, so state availability no longer applies.

Support10%

6.6/10

AMP Health no longer offers GLP-1 treatment, so there is no current patient support to assess.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this AMP Health review

Last checked August 2026
  • Checked the FDA warning-letter database for enforcement actions

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

FDA warning-letter register
An active letter is on file for this provider; see below

What we like

  • Review page kept live so readers searching for it get a straight answer

Watch-outs

  • The website shows only a maintenance page, so there is no way to sign up, see prices or reorder
  • The maintenance page still advertises a free first month, with no working way to claim it
  • It never showed LegitScript or PCAB accreditation or a physical address

AMP Health's website shows only a maintenance page, and it is not taking orders

If you came here looking for AMP Health's compounded semaglutide or tirzepatide, there is nothing to order. When we checked on October 30, 2026, its website still showed only a maintenance page, as it has since at least June 2026. There is no store, no price list and no sign-up, even though the page still advertises a free first month.

When it was selling, AMP Health offered compounded semaglutide as an injection and an oral form, plus compounded tirzepatide, with a monthly subscription fee charged on top of the medication. The site's code still referenced an older SlimMD logo, which suggests it was a rebrand of an earlier service. It never showed LegitScript or PCAB accreditation or a physical address. We treat it as closed until it comes back with a working store.

What to do if you were a patient

Talk with a prescriber before your current supply runs out. A GLP-1 dose should be continued or adjusted on clinical advice, not interrupted because a provider stopped selling, and restarting at a high dose after a gap can be unsafe. If your medication label names a pharmacy, keep that information handy, because the dispensing pharmacy is a separate business from the platform that arranged your visits.

If you were taking the oral form, bring your current dose and how long you have been on it to your first visit with a new provider, since oral and injected semaglutide are dosed very differently.

Where to look instead

The alternatives listed on this page are all currently operating and carry current prices. You can also start from our semaglutide provider rankings and compare what each provider includes as well as what it charges, using the factors in our scoring methodology.

Bottom line

AMP Health is not taking orders, and its website has shown only a maintenance page for months. We keep this page up so people searching for it get a clear answer rather than a dead link. It is excluded from our rankings and carries no outbound link.

The Bottom Line

AMP Health is no longer available as we reviewed it, so this page is kept for reference.

Score: 6.6/10Best for: former AMP Health patients looking for a current GLP-1 provider

Frequently Asked Questions

Not online. When we checked on October 30, 2026, the AMP Health website still showed only a maintenance page, as it has since at least June 2026. There is no store, price list or sign-up, so there is no working way to start or continue a program.
AMP Health sold compounded semaglutide, as an injection and an oral form, and compounded tirzepatide, with a monthly subscription fee charged on top of the medication. Compounded GLP-1s are not FDA-approved products.
Talk with a prescriber before your current supply runs out, so treatment continues without a gap or an unsafe restart dose. If your medication label names a pharmacy, keep that information, because the dispensing pharmacy is a separate business. Then compare current providers on price, medication and state coverage.
People still search for AMP Health, and a clear answer beats a dead link. This page is excluded from every ranking on this site, carries no outbound link to the old service, and points to currently operating alternatives instead.
AMP Health is an operating telehealth provider, but it has an FDA warning letter on file, which this review flags. We scored it 6.6/10 overall. Read the FDA notice before you decide. Talk to a licensed clinician before starting any medication.
The main red flag is an FDA warning letter on file, which this review flags. We also note: The website shows only a maintenance page, so there is no way to sign up, see prices or reorder; the maintenance page still advertises a free first month, with no working way to claim it; it never showed LegitScript or PCAB accreditation or a physical address.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

AMP Health received an FDA warning letter dated February 20, 2026

The letter concerns false and misleading claims and misbranded drugs. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this AMP Health review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.